Double-Digit Growth in Top and Bottom Line
Reported double-digit growth in both top and bottom line, with a 21% increase in EBIT on an organic basis and exceeding all FY '25 first half year performance objectives.
Strong Organic Sales Growth in Healthcare and Industrial
Healthcare achieved a 16% organic growth, while Industrial saw an 8% increase. This growth was driven by new products and overcoming destocking effects.
Successful KBU Integration
The KBU business exceeded expectations with a 7% sales growth and strong margins. The integration is on track to complete ahead of schedule.
Increased EPS Guidance
Confidence in the second half performance led to an increase in the overall EPS guidance range for the year.
Improved Balance Sheet Flexibility
Net debt-to-EBITDA leverage of 1.6x, which is well below expectations, providing increased balance sheet flexibility.
Record GPADE Margins
GPADE margins improved by 140 basis points due to higher margins from the KBU acquisition and operating leverage.
Strong Cash Flow and Inventory Management
Operating cash flow of just under $54 million with a healthy cash conversion of 104%. Improved inventory turns and tight management of receivables and payables.